BMEYE, a provider of noninvasive combined beat-to-beat blood pressure and cardiac output monitoring systems, and PULSION Medical Systems have reached an agreement on a worldwide, non-exclusive license which allows BMEYE's technology to be integrated into PULSION's hemodynamic patient monitoring solution.

Under the agreement, BMEYE will develop a custom made OEM module for PULSION Medical Systems, a provider of minimally invasive critical care and cardiovascular patient monitoring.

BMEYE said its technology offers the advanced cardiovascular monitoring capability, which utilises a finger cuff to capture and continuously measure beat-to-beat blood pressure and cardiac output totally noninvasively.

The detailed data allows clinicians to predict and proactively address the early signs of hemodynamic instability during critical situations rather than reacting on late indicators and effects.

PULSION’s PiCCO – Technology permits comprehensive and low-risk monitoring of cardiovascular function in critically ill patients in the intensive-care environment.

BMEYE CEO Rob de Ree said part of the BMEYE strategy is to develop the OEM channel in hemodynamic and patient monitoring and to make their technology broadly available for integrated solutions besides their sales channel and as such PULSION is a valuable partner as a European provider in the intensive care field.

PULSION CEO Patricio Lacalle said the integration of BMEYE’s noninvasive technology is another important step in building a consistent product portfolio to help patients in a broad range of different acute situations with increased risk or impaired function of the cardiovascular system.

"We are able to provide a flexible solution for hospitals by covering non-invasive and minimally invasive hemodynamic monitoring, as well as the sophisticated and highly precise PiCCO monitoring technology," Lacalle said.